487 / 884
International Journal of Radiation Oncology, Biology, Physics, 2010, Vol.76(4), pp.1061-1065
CONCLUSION: A predictive model for a postimplant nomogram for
prostate cancer recurrence at 9-years after PPB has been
developed and validated from a large multi-institutional database.
This study also demonstrates the significance of implant dosimetry
for predicting outcome.